Stroke treatment with alteplase given 3·0–4·5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial

Erich Bluhmki; Ángel Chamorro; Antoni Dávalos; Thomas Machnig; Christophe Sauce; Nils Wahlgren; Joanna M. Wardlaw; Werner Hacke

doi:10.1016/s1474-4422(09)70264-9

Stroke treatment with alteplase given 3·0–4·5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial

Authors: Erich Bluhmki, Ángel Chamorro, Antoni Dávalos, Thomas Machnig, Christophe Sauce, Nils Wahlgren, Joanna M. Wardlaw, Werner Hacke - The Lancet 2009 cited by 347

Stroke treatment with alteplase given 3·0–4·5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial | Litlas